Cagent Vascular
Developing innovative intravascular lithotripsy technology for treating calcified peripheral artery disease.
About
Technology stack
detected 2026-06-11No comments yet. Be the first to share your take.
What does Cagent Vascular do?
Cagent Vascular, Inc. is a medical device company focused on developing and commercializing innovative intravascular lithotripsy (IVL) technology. Their flagship product, the Serranator SONIC IVL System, is designed to treat calcified lesions in peripheral arteries, a common and challenging condition in patients with Critical Limb Ischemia (CLI). The company recently announced the completion of its first human-use cases with the Serranator SONIC IVL System and secured $41 million in Series D fun…
How much funding has Cagent Vascular raised?
Cagent Vascular has raised a total of $41M in funding. The most recent round on record is Series D.
Where is Cagent Vascular headquartered?
Cagent Vascular is headquartered in Wayne, Pennsylvania, USA.
When was Cagent Vascular founded?
Cagent Vascular was founded in 2015.
What industry does Cagent Vascular operate in?
Cagent Vascular operates in Medical Devices, Healthcare, Biotechnology.